Slingshot members are tracking this event:

FDA Grants Tentative Approval to Intellipharmaceutics' (IPCI) Seroquel XR for Schizophrenia and Maniac/Mixed Episodes Associated with Bipolar Disorder

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 07, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Tentative Approval, Fda, Seroquel Xr, Schizophrenia, Maniac/mixed Episodes, Bipolar Disorder